These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3603676)

  • 1. Influence of erythromycin on cyclosporine pharmacokinetics.
    Vereerstraeten P; Thiry P; Kinnaert P; Toussaint C
    Transplantation; 1987 Jul; 44(1):155-6. PubMed ID: 3603676
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
    Fabre I; Fabre G; Maurel P; Bertault-Peres P; Cano JP
    Drug Metab Dispos; 1988; 16(2):296-301. PubMed ID: 2898350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the metabolism of cyclosporine by human liver microsomes by FK506.
    Burke MD; Omar G; Thomson AW; Whiting RH
    Transplantation; 1990 Nov; 50(5):901-2. PubMed ID: 1700507
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation and mass spectrometric identification of cyclosporin A isomeric dihydrodiol precursors from erythromycin-induced rabbit liver microsomes.
    Nickmilder M; Verbeeck R; Lhoëst G
    Pharm Acta Helv; 1992; 67(9-10):275-81. PubMed ID: 1438460
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible interaction between cyclosporine and erythromycin.
    Kohan DE
    N Engl J Med; 1986 Feb; 314(7):448. PubMed ID: 3511381
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of cyclosporin A. II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes.
    Bertault-Peres P; Bonfils C; Fabre G; Just S; Cano JP; Maurel P
    Drug Metab Dispos; 1987; 15(3):391-8. PubMed ID: 2886317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK 506 inhibition of cyclosporine metabolism by human liver microsomes.
    Omar G; Shah IA; Thomson AW; Whiting PH; Burke MD
    Transplant Proc; 1991 Feb; 23(1 Pt 2):934-5. PubMed ID: 1703356
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of cyclosporine.
    Maurer G
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):19-26. PubMed ID: 3895660
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction between erythromycin and cyclosporine in a kidney and pancreas allograft recipient.
    Wadhwa NK; Schroeder TJ; O'Flaherty E; Pesce AJ; Myre SA; Munda R; First MR
    Ther Drug Monit; 1987; 9(1):123-5. PubMed ID: 3554626
    [No Abstract]   [Full Text] [Related]  

  • 10. Depression of theophylline metabolism and elimination by troleandomycin and erythromycin.
    Hemsworth TC; Renton KW
    Biochem Pharmacol; 1981 Jun; 30(11):1299-304. PubMed ID: 6973975
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of cyclosporin and calcium antagonists.
    Wagner K; Philipp T; Heinemeyer G; Brockmüller F; Roots I; Neumayer HH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1453-6. PubMed ID: 2652465
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of cyclosporine metabolism by other drugs in vitro.
    Henricsson S; Lindholm A
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):569-71. PubMed ID: 3284104
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporin. Pharmacokinetics and metabolism.
    Lemaire M; Maurer G; Wood AJ
    Prog Allergy; 1986; 38():93-107. PubMed ID: 3725757
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and identification of a novel isomerized epoxide metabolite of FK-506 from erythromycin-induced rabbit liver microsomes.
    Lhoëst G; Maton N; Verbeeck RK
    Drug Metab Dispos; 1993; 21(5):850-4. PubMed ID: 7694828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of cyclosporine metabolites produced in a hepatic microsomal system.
    Cheung F; Wong PY; Cole E; Cohen Z; Levy GA
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):633-6. PubMed ID: 3363659
    [No Abstract]   [Full Text] [Related]  

  • 16. The erythromycin breath test as a predictor of cyclosporine blood levels.
    Watkins PB; Hamilton TA; Annesley TM; Ellis CN; Kolars JC; Voorhees JJ
    Clin Pharmacol Ther; 1990 Aug; 48(2):120-9. PubMed ID: 2116259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.
    Kronbach T; Fischer V; Meyer UA
    Clin Pharmacol Ther; 1988 Jun; 43(6):630-5. PubMed ID: 3378384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding spectra of rat renal and hepatic microsomal cytochromes P-450 with cyclosporine A.
    Machková Z; Mostecká H; Seifert J; Masek K
    Methods Find Exp Clin Pharmacol; 1991; 13(1):57-61. PubMed ID: 1870359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
    Pichard L; Fabre I; Fabre G; Domergue J; Saint Aubert B; Mourad G; Maurel P
    Drug Metab Dispos; 1990; 18(5):595-606. PubMed ID: 1981707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel antagonists and cyclosporine metabolism: in vitro studies with human liver microsomes.
    Tjia JF; Back DJ; Breckenridge AM
    Br J Clin Pharmacol; 1989 Sep; 28(3):362-5. PubMed ID: 2789931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.